Dr. Parth Rali Provides Perspective for Medscape on TETON-1 Data Presented at ATS on Inhaled Treprostinil for Adults With IPF

Parth M. Rali, MD, FCCP, Director of the Temple Health Pulmonary Embolism Response Team (PERT) Program, Section Temple Lung PVD Program, provided perspective for a Medscape article on new data on the TETON-1 study presented at the ATS International Conference and simultaneously published in The New England Journal of Medicine. The phase-3 study found the use of inhaled treprostinil significantly preserved lung function in adults with idiopathic pulmonary fibrosis (IPF). Rali was a site investigator of the study.